The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells

Annalucia Serafino; Ewa Krystyna Krasnowska; Sabrina Romanò; Alex De Gregorio; Marisa Colone; Maria Luisa Dupuis; Massimo Bonucci; Giampietro Ravagnan; Annarita Stringaro; Maria Pia Fuggetta

doi:10.20944/preprints202408.0553.v1

How to cite: Serafino, A.; Krasnowska, E. K.; Romanò, S.; De Gregorio, A.; Colone, M.; Dupuis, M. L.; Bonucci, M.; Ravagnan, G.; Stringaro, A.; Fuggetta, M. P. The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells. Preprints 2024, 2024080553. https://doi.org/10.20944/preprints202408.0553.v1 Serafino, A.; Krasnowska, E. K.; Romanò, S.; De Gregorio, A.; Colone, M.; Dupuis, M. L.; Bonucci, M.; Ravagnan, G.; Stringaro, A.; Fuggetta, M. P. The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells. Preprints 2024, 2024080553. https://doi.org/10.20944/preprints202408.0553.v1

Abstract

Glioblastoma (GBL) is one of the more malignant primary brain tumors, currently treated by a multimodality strategy including surgery, radio- and chemotherapy, mainly consisting of Temozolomide(TMZ)-based chemotherapy. Tumor relapse often occurs due to the establishment of TMZ resistance, with a patient median survival

Keywords

Subject

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells

Abstract

Keywords

Subject

Comments (0)